-Search query
-Search result
Showing 1 - 50 of 153 items for (author: joel & quispe)
EMDB-41986:
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM
EMDB-41989:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42012:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42026:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42029:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7m:
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7q:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7v:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u8o:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u8y:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-41784:
PRD-0038 RBD bound to Rhinolophus alcyone ACE2 (local refinement)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-41786:
PRD-0038 RBD bound to R. alcyone ACE2
Method: single particle / : Park YJ, Veesler D
EMDB-41842:
Prefusion structure of the PRD-0038 spike glycoprotein ectodomain trimer
Method: single particle / : Lee J, Park YJ, Veesler D
EMDB-41843:
PRD-0038 Spike glycoprotein NTD
Method: single particle / : Lee J, Park YJ, Veesler D
PDB-8u0t:
PRD-0038 RBD bound to Rhinolophus alcyone ACE2 (local refinement)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-8u29:
Prefusion structure of the PRD-0038 spike glycoprotein ectodomain trimer
Method: single particle / : Lee J, Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-29530:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-29531:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-40240:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxb:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxc:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8s9g:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-27279:
Human PRPS1 with Phosphate; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27280:
Human PRPS1 with Phosphate; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27281:
Human PRPS1 with ADP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27282:
Human PRPS1 with ADP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27283:
Human PRPS1 with Phosphate and ATP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27284:
Human PRPS1 with Phosphate and ATP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27285:
Human PRPS1 with Phosphate, ATP, and R5P; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27286:
Human PRPS1 with Phosphate, ATP, and R5P; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27287:
Human PRPS1 with Phosphate, ATP, and R5P; Hexamer with resolved catalytic loops
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27288:
Human PRPS1 with Phosphate, ATP, and R5P; Hexamer with resolved catalytic loops
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27289:
Human PRPS1 with Phosphate and PRPP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27290:
Human PRPS1 with Phosphate and PRPP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27291:
Human PRPS1-E307A engineered mutation with Phosphate, ATP, and R5P; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27292:
Human PRPS1-E307A engineered mutation with Phosphate, ATP, and R5P; Symmetry-expanded Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27293:
Human PRPS1-E307A engineered mutation with ADP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27294:
Human PRPS1-E307A engineered mutation with ADP; Symmetry-expanded Hexamer 1
Method: single particle / : Hvorecny KL, Kollman JM
EMDB-27295:
Human PRPS1-E307A engineered mutation with ADP; Symmetry-expanded Hexamer 2
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbc:
Human PRPS1 with Phosphate; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbd:
Human PRPS1 with Phosphate; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbe:
Human PRPS1 with ADP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbf:
Human PRPS1 with ADP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbg:
Human PRPS1 with Phosphate and ATP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbh:
Human PRPS1 with Phosphate and ATP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbi:
Human PRPS1 with Phosphate, ATP, and R5P; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbj:
Human PRPS1 with Phosphate, ATP, and R5P; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbk:
Human PRPS1 with Phosphate, ATP, and R5P; Hexamer with resolved catalytic loops
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbl:
Human PRPS1 with Phosphate and PRPP; Hexamer
Method: single particle / : Hvorecny KL, Kollman JM
PDB-8dbm:
Human PRPS1 with Phosphate and PRPP; Filament Interface
Method: single particle / : Hvorecny KL, Kollman JM
Pages: